Intact Investment Management Inc. Takes $1.22 Million Position in Xylem Inc. $XYL

Intact Investment Management Inc. acquired a new position in shares of Xylem Inc. (NYSE:XYL) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 8,300 shares of the industrial products company’s stock, valued at approximately $1,224,000.

A number of other large investors have also recently bought and sold shares of XYL. Norges Bank acquired a new position in shares of Xylem in the second quarter worth $338,232,000. ABN AMRO Bank N.V. acquired a new position in Xylem in the 2nd quarter valued at about $208,226,000. Swedbank AB boosted its stake in shares of Xylem by 19.0% during the 3rd quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after purchasing an additional 830,821 shares during the last quarter. Amundi grew its holdings in shares of Xylem by 17.0% during the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock worth $730,717,000 after buying an additional 830,337 shares in the last quarter. Finally, Voya Investment Management LLC raised its position in shares of Xylem by 544.0% in the third quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock valued at $128,141,000 after buying an additional 733,860 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Analysts Set New Price Targets

XYL has been the topic of a number of analyst reports. William Blair initiated coverage on shares of Xylem in a research report on Monday. They set an “outperform” rating on the stock. UBS Group raised their price objective on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. Stifel Nicolaus upped their target price on Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Zacks Research downgraded Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Nine investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.80.

Insider Buying and Selling at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. This represents a 25.01% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the sale, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is owned by corporate insiders.

Xylem Price Performance

XYL stock opened at $143.38 on Tuesday. The company has a market cap of $34.91 billion, a PE ratio of 36.86, a price-to-earnings-growth ratio of 2.00 and a beta of 1.17. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. The stock has a 50-day moving average price of $139.71 and a two-hundred day moving average price of $141.69. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $154.27.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. During the same period last year, the business posted $1.11 EPS. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. As a group, research analysts predict that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date was Tuesday, November 25th. Xylem’s payout ratio is currently 41.13%.

Xylem Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.